RecruitingNot Applicable

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

United States180 participantsStarted 2025-07-08

Plain-language summary

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Who can participate

Age range18 Years – 47 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * No none contraindications to IVF or PRP treatment * Adequate ovarian reserves and AMH level * Willingness to undergo two IVF cycles and oPRP treatment Exclusion Criteria: * Anovulation due to menopause or perimenopause * Any health conditions that are contraindicated for IVF or oPRP treatment

What they're measuring

Blastocyst formation and embryo quality

Timeframe: 1 year

Trial details

NCT IDNCT07020546

SponsorGeneration Next Fertility

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Alicia L Broussard, PhD

3174456958 a.broussard@generationnextfertility.com

View on ClinicalTrials.gov More Infertility trials